Breast cancer cells also upregulated the expression of PD-1, TIM-3 and/or LAG-3, but not CTLA-4, in CD4+CD25+ T cells (comprising of activated T cells and Tregs). This evidence concerns the gene HAVCR2 and breast cancer.